Discover 3,032 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,032
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
for
Hypertensive Disorders of Pregnancy, Preeclampsia,
Location: Los Angeles CA, San Francisco CA, Salt Lake City UT,
Sponsor: Ohio State University
Sex: Female
Age: 14 - 35
Code: NCT06468202
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
for
Chronic Kidney Disease
Location: Glendale CA, San Antonio TX, Saint Paul MN, Chicago IL
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07024823
Phase1, Recruiting
Diet in the Management of Acromegaly
for
Acromegaly
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT05401084
Recruiting
Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
Stem Cells Found in the Abdominal Cavity in Humans
for
Intra-abdominal Surgery
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18 - 60
Code: NCT00576264
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Improving Behavioral Health for Caregivers and Children After Pediatric Injury
for
Quality of Life, PTSD, Depression Not Otherwise Specified,
Location: Los Angeles CA, Houston TX, Lexington KY, Ann Arbor MI
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT06856057
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Los Angeles CA, Sacramento CA, Phoenix AZ, Murray UT,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT06388421
Recruiting
Cord Clamping Among Neonates With Congenital Heart Disease
for
Congenital Heart Disease (CHD)
Location: Los Angeles CA, San Diego CA, Salt Lake City UT,
Sponsor: Carl Backes, MD
Sex: All
Age: 0
Code: NCT06153459
Recruiting
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
for
Cushing Disease
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT05971758
Phase2, Recruiting
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
for
Single-ventricle, Stenosis
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles
Sex: All
Age: 12 - 21
Code: NCT07073612
Recruiting
SynCardia 70cc TAH-t for Destination Therapy (DT)
for
Life-threatening, Biventricular Heart Failure,
Location: Los Angeles CA, Phoenix AZ, Tucson AZ, Oklahoma City OK,
Sponsor: SynCardia Systems. LLC
Sex: All
Age: 19+
Code: NCT02232659
Recruiting
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Torrance CA, South Pasadena CA, Arcadia CA, Duarte CA,
Sponsor: City of Hope Medical Center
Sex: Female
Age: 40+
Code: NCT06954831
Phase2, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Los Angeles CA, Tucson AZ, Oregon City OR, Newberg OR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Los Angeles CA, Fullerton CA, Portland OR,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase2, Recruiting
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
for
CTCL
Location: Duarte CA, Irvine CA, Rochester NY, Richmond VA,
Sponsor: Prescient Therapeutics, Ltd.
Sex: All
Age: 18+
Code: NCT06854653
Phase2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer
Location: Los Angeles CA, Newport Beach CA, Reno NV, Chandler AZ,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase2, Phase3, Recruiting
External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease
for
Extramedullary Disease in Multiple Myeloma, Multiple Myeloma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06572605
Phase1, Phase2, Recruiting
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)